Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 355 participants.

Also called NCT07582835

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 355 participants (planned count) (from the registry)
Sponsor
Cardiocentro Ticino (from the registry)
Registry
  • NCT NCT07582835
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07582835. Randomized; no masking; primary purpose treatment. Start 2026-04-20 (anticipated); primary completion 2028-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
Acronym
HI-TECH 2
Condition
Acute Coronary Syndromes
Condition
Antiplatelet Therapy
Condition
Single Antiplatelet Therapy
Condition
Coagulation Factors
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Ticagrelor
Intervention (Drug)
Prasugrel
Lead sponsor
Cardiocentro Ticino (class: other)

Record details

Record id
cardio:ct-nct07582835
Content hash
854df28a804cde19f9cb96d6fcfcc60bdd32f054f73bc048503e4f672c9a9132